LC-MS biomarker diagnostics for neuroinflammatory disorders

LC-MS biomarker diagnostics for neuroinflammatory disorders

Bibliographic Details
Main Authors:	M. Morrens, V. Coppens
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396422001682

Similar Items

Biomarker identification by LC-MS/MS for patients with brain injury.
by: Teena.
Published: (2009)

Biomarker identification by LC-MS/MS for patients with brain injury.
by: Low, Keng Cheng.
Published: (2009)

Exploring potential biomarkers for lung adenocarcinoma using LC-MS/MS metabolomics
by: Liang Mo, et al.
Published: (2020-04-01)

Establishment of Protocols for Global Metabolomics by LC-MS for Biomarker Discovery.
by: Daisuke Saigusa, et al.
Published: (2016-01-01)

Identification of novel biomarkers for varicocele using iTRAQ LC-MS/MS technology
by: Xianfeng Lu, et al.
Published: (2024-02-01)

Simultaneous Quantitation of Lipid Biomarkers for Inflammatory Bowel Disease Using LC–MS/MS
by: Yashpal S. Chhonker, et al.
Published: (2021-02-01)

Joint Microbiota Activity and Dietary Assessment through Urinary Biomarkers by LC-MS/MS
by: Victoria Ramos-Garcia, et al.
Published: (2023-04-01)

Detection of a Serum Siderophore by LC-MS/MS as a Potential Biomarker of Invasive Aspergillosis.
by: Cassandra S Carroll, et al.
Published: (2016-01-01)

Addiction, Anhedonia, and Comorbid Mood Disorder. A Narrative Review
by: Marianne Destoop, et al.
Published: (2019-05-01)

Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
by: Michele Protti, et al.
Published: (2022-09-01)

Clinical relevance of guanine-derived urinary biomarkers of oxidative stress, determined by LC-MS/MS
by: Ying-Ming Shih, et al.
Published: (2019-01-01)

Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq
by: Fan Zhang, et al.
Published: (2020-12-01)

The Interplay of Inflammatory Processes and Cognition in Alcohol Use Disorders—A Systematic Review
by: Violette Coppens, et al.
Published: (2019-09-01)

Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.
by: Jian Zhang, et al.
Published: (2012-01-01)

Development and validation of a multiplexed LC-MS/MS ketone body assay for clinical diagnostics
by: Robin H.J. Kemperman, et al.
Published: (2024-01-01)

Free complement and complement containing extracellular vesicles as potential biomarkers for neuroinflammatory and neurodegenerative disorders
by: Marlies Burgelman, et al.
Published: (2023-01-01)

Neuroinflammatory Hypothesis in Major Depressive Disorder
by: Gulfizar Sozeri-Varma
Published: (2014-02-01)

Correction: Detection of a Serum Siderophore by LC-MS/ MS as a Potential Biomarker of Invasive Aspergillosis.
by: Cassandra S Carroll, et al.
Published: (2016-01-01)

Application of LC–MS/MS in the Mycotoxins Studies
by: Laura Gámiz-Gracia, et al.
Published: (2020-04-01)

Utilizing MALDI-TOF MS and LC-MS/MS to access serum peptidome-based biomarkers in canine oral tumors
by: Sekkarin Ploypetch, et al.
Published: (2022-12-01)

LC-MS/MS Based Metabolomics Reveal Candidate Biomarkers and Metabolic Changes in Different Buffalo Species
by: Wen Shi, et al.
Published: (2021-02-01)

LC-MS/MS Based Volatile Organic Compound Biomarkers Analysis for Early Detection of Lung Cancer
by: Shuaibu Nazifi Sani, et al.
Published: (2023-02-01)

Intact glycopeptides identified by LC-MS/MS as biomarkers for response to chemotherapy of locally advanced cervical cancer
by: Jing Li, et al.
Published: (2023-07-01)

Identification of biomarker in patients on high dose warfarin : an iTRAQ-coupled LC-MS/MS approach
by: Lee, Joanne Hui Yi.
Published: (2009)

Identification of biomarker in patients on low dose warfarin : an iTRAQ-coupled LC-MS/MS approach
by: Koh, Regina Hwee Chen.
Published: (2009)

LC-MS in Quantitative Analysis
by: Niessen, W.M.A.
Published: (2000-08-01)

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
by: Catarina M. Abreu, et al.
Published: (2018-05-01)

Largazole Pharmacokinetics in Rats by LC-MS/MS
by: Mingming Yu, et al.
Published: (2014-03-01)

Determination of specific iron chelator by using LC-ICP-MS and LC-ESI-MS
by: Mohamed, Khairul Nizam, et al.
Published: (2015)

Pigments’ analysis of Citrus juicing making by‐products by LC‐MS/MS and LC‐DAD
by: Eleni D. Myrtsi, et al.
Published: (2022-01-01)

LC-MS/MS in proteomics : methods and applications /
by: Cutillas, Pedro R., et al.
Published: (c201)

Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines
by: Michael R. Pranzatelli, et al.
Published: (2018-04-01)

Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
by: Jun Kou, et al.
Published: (2022-04-01)

Discovery of potential biomarkers for osteoporosis using LC/GC−MS metabolomic methods
by: Yahui Wu, et al.
Published: (2024-01-01)

Identification of potential biomarkers for diabetic cardiomyopathy using LC-MS-based metabolomics
by: Run-Qing Xiong, et al.
Published: (2024-01-01)

LC-MS and CE-MS Strategies in Impurity Profiling
by: Wilfried M.A. Niessen
Published: (1999-10-01)

LC-MS and CE-MS Strategies in Impurity Profiling
by: Wilfried M.A. Niessen
Published: (1999-10-01)

Method development and validation of cabozantinib by LC-MS/MS
by: Punna Venkateshwarlu, et al.
Published: (2022-05-01)

Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
by: Jessica Cohen, et al.
Published: (2024-03-01)

LC-MS Based Platform Simplifies Access to Metabolomics for Peroxisomal Disorders
by: Henry Gerd Klemp, et al.
Published: (2021-05-01)